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Background This review assessed the case definitions, diagnostic criteria, antimicro-
bial resistance, and methods used for enteric fever outbreaks and utilization of any 
unified outbreak score or checklist for early identification and response in Asia and 
Africa from 1965-2019.
Methods We searched enteric fever outbreaks using PubMed, Google Scholar, and 
the Cochrane library. Studies describing a single outbreak event of enteric fever in 
Asia and Africa from 1965-2019 were reviewed. We excluded case reports, letter to 
editors, studies reporting typhoid in conjunction with other diseases, the Centers for 
Disease Control and Prevention (CDC) trip reports, the World Health Organization 
(WHO) bulletins report, data from mathematical modeling and simulation studies, 
reviews and ProMed alert. Also, non-typhoidal salmonella outbreaks were excluded.
Results A total of 5063 articles were identified using the key terms and 68 studies 
were selected for data extraction. Most (48, 71%) outbreaks were from Asian coun-
tries, 20 (29%) were reported from Africa. Only 15 studies reported the case defini-
tion used for case identification during an outbreak and 8 of those were from Asia. A 
third (20, 29%) of the studies described antibiotic resistance pattern. 43 (63%) studies 
contained information regarding the source of the outbreak. Outcomes (hospitaliza-
tion and deaths) were reported in a quarter of studies. Only 23 (29%) of the studies 
reported outbreak control strategies while none reported any unified outbreak score 
or a checklist to identify the outbreak.
Conclusion This review highlights the variability in detection and reporting methods 
for enteric fever outbreaks in Asia and Africa. No standardized case definitions or lab-
oratory methods were reported. Only a few studies reported strategies for outbreak 
control. There is a need for the development of a unified outbreak score or a checklist 
to identify and report enteric fever outbreaks globally.
Cite as: Khaliq A, Yousafzai MT, Haq S, Yaseen R, Quershi S, Rind F, 
Padhani ZA, Khan A, Kazi AM, Wamar FN. J Glob Health 2021;11:04031.
Enteric fever is a major public health concern especially in low middle-income countries 
(LMICs) [1]. The disease is caused by subspecies enterica serovar Typhi (S. typhi) and Para-
typhi (S. paratyphi). Typhi is responsible for causing typhoid fever, while Enteric fever is a 
group of enteric infection caused by Salmonella enterica. The Salmonella enterica has differ-
ent subspecies serovars, which are responsible to cause varying types of enteric infections, 
such as typhoid fever by S. typhi and paratyphoid fever by S. paratyphi A, B, and C [2,3]. 
The disease is characterized by high-grade fever, fatigue, malaise, headache, and certain 
gastrointestinal symptoms including abdominal pain, diarrhea, or constipation [3,4]. The 
disease is highly endemic in most of the LMICs. Compared with industrialized nations, 
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people living in Asian and African countries are vulnerable to enteric fever. Despite having high endemicity of 
enteric fever, the disease cannot be diagnosed clinically from the clinical sign and symptoms [5].
The symptoms of enteric fever are non-specific and are closely relate to other febrile illnesses, such as malaria, 
dengue, and influenza [5]. Clinicians preferred to diagnose enteric fever with serological and other laboratory 
tests for diagnosing enteric fever. The Widal test, Typhi dot and Tubex-M test are the commonly prescribed 
serological tests for the initial diagnosis of enteric fever [6]. However, for the confirmatory diagnosis of enter-
ic fever, blood, bone marrow or other body specimen is recommended. Among different body specimen, the 
bone marrow culture has the highest sensitivity of 96% for Salmonella species. Despite bone marrow culture 
highest sensitivity, blood culture is considered as the gold standard for the confirmatory diagnosis of enteric 
fever, because it is less invasive compared with bone marrow culture. The culture sensitivity of blood culture 
decreased to around 30% from 60% in patients having less than a week symptoms history and in patients with 
a history of antimicrobial use [7-10]. The rising antimicrobial resistance against S. typhi is a global threat. The 
antimicrobial agents, such as amoxicillin, chloramphenicol and co-trimoxazole served as the first line of choice 
for treating enteric fever, however, globally more than a third of the population is resistant to these agents 
[1,11]. Enteric fever patients who are resistant to amoxicillin, chloramphenicol and co-trimoxazole are found 
to have Multidrug Resistance (MDR) enteric fever [12]. The emergence of MDR enteric fever in the late 1980s 
and the early 1990s has shifted the therapeutic choice to second-generation fluoroquinolones and third-gen-
eration cephalosporins [13,14]. Still, the issues related to therapeutic failure reported due to the emergence of 
Fluoroquinolones resistance (FQR) and Extensive Drug Resistance (XDR) [11,14,15]. The XDR enteric fever 
was first observed in November 2016 from the southern parts of Pakistan. The therapeutic management of 
XDR enteric fever seems like a medical challenge for the health practitioners, because of the limited choice of 
antibiotics. In general, the macrolides (Azithromycin) and carbapenems (Meropenem or Imipenem) are rec-
ommended for treating XDR enteric fever cases [16-18].
The global burden of enteric fever is not homogenous. Most of the Asian and African countries are highly en-
demic to enteric fever. The incidence rate of enteric fever in most of the Asian and African countries ranged 
from 100 to 700 per 100 000 population, while the incidence rate of enteric fever in other regions is less than 
15 per 100 000 [3]. Factors, such as living in urban slums, inaccessibility to safe drinking water, restaurant 
or cafeteria food, close contact with enteric fever patients and prior use of antibiotics significantly increased 
the risk of enteric fever [18,19]. People living in Asian,  African, and Latin American countries are deprived 
of safe drinking water, adequate sanitation, and proper shelter, which in turn are responsible for many com-
municable and infectious diseases including enteric fever [19,20]. In this regard, it is essential to know about 
the case definitions, diagnostic criteria, antimicrobial resistance, methods used for outbreaks control and use 
of any unified outbreak scoring or a checklist for the identification of enteric fever outbreaks in Asia and Af-
rica from 1965-2019.
METHODS
We searched PubMed, Google Scholar and the Cochrane library using a combination of Medical Subjects 
Heading (MeSH) and Keywords, i.e, “Salmonella Infections” [Mesh] OR “Typhoid Fever” [Mesh] OR “Para-
typhoid fever” OR “Enteric fever” AND “Disease Outbreaks”[Mesh] OR outbreak*. In addition, filters for the 
publication year from 1965 to May 25, 2019, English language and human studies were used (where appli-
cable) (Supplementary file 1). All studies indicating documentation of clinical features, based on title and/or 
abstract, were retrieved in the full text where available.
We conducted a parallel search to examine the included studies reference lists and pertinent systematic re-
views for additional studies.
Eligibility criteria
We considered original research articles that described at least one outbreak event of enteric fever in humans 
from 1965 to May 2019. We included all those studies that described enteric fever (typhoid or paratyphoid) 
outbreak event in Asia and Africa irrespective of age, gender, institutional setting, treatment method and 
source of transmission. Studies with enteric fever cases identified based on clinical criteria alone or confirmed 
by culture (blood, bone marrow, stool, or any other sterile fluid) or serology (Widal test/Typhi Dot test), were 
included. We excluded case reports studies using a clinical diagnosis only, letter to editors, studies reporting 
typhoid in conjunction with other diseases, CDC trip reports, WHO bulletins report, data from mathematical 
modeling and simulation studies, reviews and ProMed alerts (Table 1).
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Studies published from the same hospital/region 
and during the same time were considered as du-
plicate/overlapping data and counted once.
Screening process
All papers searched through different databases 
were imported into the endnote library. Duplicate 
records were removed. Two co-authors (AK and 
FR) independently initiated the screening of the 
papers. In the first step, titles and abstracts were 
independently screened and ineligible records 
were excluded. At the end of the first phase of 
screening, both reviewers met and discussed the 
papers included and excluded. The third reviewer 
(ZF) resolved any disagreements between the two 
independent reviewers. The second screening was 
based on a full-text review of the remaining pa-
pers. Again, AK and FR reviewed the full text of all 
papers and any paper not fulfilling the eligibility 
criteria was excluded. Disagreements between the 
two reviewers were resolved by the third review-
er (ZF). The remaining papers after the second 
screening were used for data extraction. The whole 
screening process with the number of records is 
provided in the PRISMA flowchart (Figure 1).
Data extraction, management, and 
analysis
We created an excel sheet for data extraction. The 
excel sheet included variables such as first author 
name, year of publication, country of publication, 
study design, the case definition for enteric fever, 
number of cases based on culture confirmation, 
serological testing and/or clinical suspected, diag-
nostic methodology used for identifying the out-
break, tool or a unified score system to identify the 
outbreak, source of the outbreak (water or food 
item reported as the source for transmitting the 
outbreak), number of hospitalizations (number of 
studies reporting any hospitalization and the pro-
portion of affected people hospitalized for typhoid 
during the outbreak), antimicrobial resistance or 
sensitivity, control measures, the effectiveness of 
the control measures or strategies in containing 
the outbreak. Data extraction was performed by 
the two co-authors (SH and RY) and any disagreements in data extraction were addressed by the third co-au-
thor SQ.
Extracted data were classified into studies based on reported outcomes, age distribution, and geographical re-
gions and by the outbreak periods. Frequency tables by country and region for each outcome variable were 
tabulated in Microsoft Excel latest version (Microsoft Inc, Seattle, WA, USA).
RESULTS
A total of 5063 studies were extracted (2506 from PubMed, 2545 from Cochrane library and 12 studies were 
from Google Scholar). Additional 56 records were identified through cross-referencing, making the total re-
cords N = 5119. There were 62 duplicates, which were removed, and the remaining 5057 records were used 
Table 1. List of exclusion criteria
Case-reports




Not published in the English language
Reports or bulletin of WHO, CDC and ProMed alerts
Enteric fever outbreaks before 1965
Studies showing no evidence of enteric fever outbreak
outbreaks due to  Non-typhoid Salmonella
Enteric fever outbreaks outside –Asia and Africa
other diseases discussed along with enteric fever outbreak
Mathematical Modeling and simulation studies
Outbreaks from the same hospital/region and during the same period were considered once
Same hospital/region and during the same period were considered
Narrative reviews
Systematic reviews
Figure 1. PRISMA flow diagram.
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for screening. The selection process is illustrated in the PRISMA study flow diagram (Figure 1). A total of 68 
studies were included for the final review.
55 studies were selected based on more than one inclusion criteria.
Geographical Distribution of Enteric Fever Outbreak in Asia and Africa
Of the 68 selected studies, 48 were from Asia and 20 from Africa. Spatial distribution of the outbreaks is pre-
sented in the geospatial map (Figure 2).
The first outbreak of enteric fever from Asia was reported from India in 1975 while in Africa, it was reported 
from South Africa in 1978. From 1976 to 1986, 5 studies regarding outbreaks were identified, 3 from Asia and 
2 from Africa. The number of outbreak studies retrieved increased continuously in the succeeding decades ie, 
17, 19 and 26 in the periods1987-97, 1998-08, and 2009-19 respectively.
Enteric fever case definitions
There were 15 studies, which reported a case definition of enteric fever for the identification of cases in the 
outbreak. Among these 15 studies, 8 (53%) studies were from Asia and 7 (47%) from Africa.
Presence of fever along gastrointestinal disorders (ie, abdominal discomfort, diarrhea, constipation, nausea, 
vomiting) as case definition criteria for enteric fever was used in seven papers from 6/7 (86%) from Africa and 
1/8 (12.5%) from Asia. Fever exceeding 37.5°C or 38.0°C for more than 3 days was used as a case definition 
in two studies. In six studies fever greater than 38°C was either alone or along with headache. The various case 
definitions used are presented in Table 2.
2-3 African studies used the presence of intestinal perforation, negative malarial parasite test and failure to re-
spond to anti-malarial treatment as a definition of enteric fever. Table 1 shows the details of clinical signs used 
for defining a case of enteric fever in an outbreak setting. None of the studies reported the use of any unified 
scoring or a tool for the identification of enteric fever outbreak.
Figure 2. Geographical distribution of Enteric fever outbreaks in different countries of Asia and Africa.
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Uganda 2009 * * † † † † †
Uganda 2009-2011 * * † † † †
Zimbabwe 2011-2012 * † † † * * *
Zimbabwe 2012 * † † † * * * *
Zimbabwe 2012 * † † † † * *
Uganda 2015 * † † † † † † † †





Jordan 1989 * † †
Myanmar 2000 * † † †
Nepal 2002-2004 *
Pakistan 2004 * * * * *
Singapore 2007 † † * † †
Singapore 2007 † * † †
China 2010 * *
*Studies support that the sign must be present.
†Studies support that the sign may be present along with other symptoms.
Enteric fever laboratory diagnostic methods
Only 25 studies provided information regarding enteric fever laboratory confirmation. Out of which, 17/25 
(68%) studies were from Asia and 9/25 (36%) were of African origin. The definition for a laboratory-confirmed 
case of enteric fever was presented by only 3/25 (12%) studies, where a laboratory-confirmed case was de-
fined as the presence of S. typhi or S. paratyphi in the blood (n = 3), stool (n = 3) or any other body fluids cultures 
urine (n = 2) and bone-marrow (n = 1). However, there were 4/25 (16%) studies in which screening test, such 
as, Widal test and Tubex TF were performed. The screening test performed in Asian countries was the Widal 
test, whereas in African studies Tubex TF was commonly advised. Out of these four studies, only one present-
ed probable case definition of enteric fever based on a positive serological test (Widal’s test, typhidot, tubex). 
There were 20/25 (80%) studies in which blood culture ordered for the confirmation of enteric fever (Table 3).
Antimicrobial resistance of enteric fever
20 studies, 15(75%) from Asia and 5 (25%) from Africa reported the antimicrobial sensitivity pattern of the 
isolates identified in the outbreak. 15 (75%) studies reported MDR isolates, 4 (20%) reported FQR, and one 
(5%) study reported XDR S. typhi isolate during the outbreak.
In the Asian region, the first reported case of MDR was observed in Pakistan in 1988. Later, a series of MDR 
isolates were reported from other Asian countries: Bangladesh in 1989, India in 1990, Iran in 1992, Tajikistan 
in 1997, Thailand in 1999, Nepal in 2002 and China in 2006. In African countries, MDR was first observed 
in 2004 in Kenya and later in Uganda in 2011. The cases of FQR were first reported from Tajikistan in 1997, 
followed reports from Kenya and Nepal also. (Table 4).
Enteric fever outbreak source investigation
Out of 68 selected studies, a total of 41 (60%) studies contained information regarding the source of enter-
ic fever outbreak. Among these 41 studies, 33 (80%) were of Asian origin while 8 (20%) were from Africa. 
In addition, there were 11 (25%) studies, in which more than one source of the outbreak was reported. The 
sources of outbreaks were broadly categorized into 4 categories: water contamination, food contamination, 
carrier transmission and inappropriate sanitation & hygiene. Table 4 shows the sources of the outbreaks by 
country and regions.
Inappropriate sanitation and water contamination were identified as the major cause of enteric fever out-
breaks in both Asian and African countries. There were 20 (50%) and 17 (41%) studies in which inappropri-
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Screening test Laboratory confirmed test
Widal test 
(n = 3)












Tunisia 2004-05 * *
Zimbabwe 2007 * * *
Uganda 2009 * *
Uganda 2009 * *
Zambia 2010-12 * *





Singapore 1979 * * *
Israel 1985 *
Pakistan 1988 *
Bangladesh 1989-90 * * †
India 1990 *
India 1997 *





China 2010 * *





















Africa (n = 5)
Kenya 2004 * ††
Tunisia 2004 – – – –
Uganda 2009 – – – –
Uganda 2011 *
Kenya 2014 ‡








Tajikistan 1997 * § ‖
Thailand 1999 * ‖
India 2000 * ¶
Nepal 2002 * *
China 2006 *
Nepal 2009 §
Thailand 2009 – – – –
India 2010 *
MDR – multidrug resistance, FDR – fluoroquinolone drug resistance, XDR – extensive drug 
resistance
†Strains were resistant to chloramphenicol.
‡Resistance to ciprofloxacin 54% in tested strains.
§Strains were resistant to nalidisic acid but sensitive to floroquinolones.
‖Strains were resistant to streptomycin and tetracycline.
¶Strains were resistant to tetracycline.
ate sanitation and fecal contamination of drink-
ing water were identified as the leading cause for 
the spread of the enteric fever. Similarly, there 
were 12 (29%) studies in which food contami-
nation was identified as other associated cause 
for enteric fever outbreak transmission. Differ-
ent food items responsible for the spread of en-
teric fever outbreak were cowpea salad, coconut 
milk, cream cake, dessert buns, fish, mashed 
potatoes, meat, mousse cake, noodles, oysters, 
raw chicken, raw pork, raw vegetables, rice, and 
sweets. The food-borne enteric fever outbreaks 
were only reported from Asian countries and 
were observed in China, India, Jordan, Singa-
pore, Saudi Arabia, and India. There were 6 
(15%) studies that testified transmission of en-
teric fever from person to person, ie, close con-
tact with Typhi positive cases, food caterer or 
cook (Table 5).
Preventive measures for the control 
of enteric fever
The information regarding different preventive 
strategies for controlling enteric fever outbreak 
was presented by 15 (36%) studies. The differ-
ent preventive strategies used as a response to 
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the outbreak were health education, mass immu-
nization, building and construction of sewerage 
plant and pipelines, water disinfection and leg-
islations to control the progression of the out-
break (Table 6).
DISCUSSION
In this systematic review, we observed only 68 
studies published from 1965 to 2019 were eli-
gible for data extraction. Likewise, outbreaks of 
enteric fever occurred in geographical clusters, 
resulting in the majority of the reports from only 
a few large countries such as India and China. 
While there were no reports of enteric fever out-
breaks available until 1975, in the succeeding 
decades a continuous increment in the number 
of reported outbreaks of enteric fever was ob-
served. No standard case definitions for a line 
listing of suspected or confirmed cases of enteric 
fever, laboratory testing, unified outbreak scor-
ing system, or a checklist was used for the iden-
tification of enteric fever outbreak. The finding of 
this systematic review including published liter-
ature from the last 50 years has important pub-
lic health and clinical implications, calling for 
an urgent need for the development of a unified 
scoring system or checklist for the identification 
of enteric fever outbreaks globally. The develop-
ment of such a unified outbreak scoring system 
or checklist will not only facilitate the early and 
timely identification of the outbreaks possible, 
but it will also make the reporting and compar-
ison of data across different countries a reality.
In Asian countries, the outbreaks of enteric fe-
ver occurred in geographical clusters. This spa-
tial clustering was observed during the outbreak 
from 1987 to 1991 in China, Pakistan, India, 
and Bangladesh. This depicts the risk that an 
outbreak reported in one geographical bound-
ary may penetrate to a neighboring geographical 
area as well. Around 70% of studies demonstrat-
ed that water contamination and inappropriate 
sanitary measures were the identified source of 
transmission. This was also supported by oth-
er studies where the disease is highly endemic 
because of lack of sanitary measures and access 
to clean water [35,36]. The risk factors of enteric fever vary within the geographical boundary [35] and no 
TRFs (Typhoid Risk Factor stratification) has been used or developed to identify inter-countries risk factor or 
source of transmission.
The increase in the number of enteric fever outbreaks in each succeeding decade could be because of the in-
crease in publication trend, reporting, and availability of online supplements. While no reports eligible for in-
clusion in this study were found during the first decade (1965-75), a gradually increasing number of papers 
published on enteric fever outbreak was found from 1976 and onwards. The changing landscape of publica-
tion tendency  over time might also have resulted in the publication of only severe form of outbreaks to be 
reported in the past while minor or small outbreaks to be reported recently, causing some form of bias in our 























































Tajikistan 1997 * * *
Thailand 1999 *
Myanmar 2000 * * *















India 2013 * * *
India 2014 * *
China 2015 *
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results. While this is possible, we did not find any difference in the level (geographic distribution) or severity 
of the outbreaks over the period.
The definition of a suspected or a clinical case of enteric fever was very heterogeneous among studies in dif-
ferent regions. In addition, enteric fever case definition varied within the same geographical region, highlight-
ing the lack of a standardized case definition for use in outbreak settings. The non-specificity of the clinical 
definition of enteric fever was also highlighted in a recent WHO report [1]. Symptoms such as fever, abdom-
inal discomfort, diarrhea, and nausea and vomiting were considered by more than 50% of studies as clinical 
criteria for diagnosis of enteric fever, however, the reporting was insufficient and inconsistent in various stud-
ies. Most outbreaks were due to an MDR isolate. An unexpectedly high number of MDR and FQR outbreaks 
were observed among the studies published after the 2000s., this might represent a publication bias because 
the number of studies published before the 2000s are very few and that cannot explain the high virulence or 
greater tendency of the spread of MDR isolates. Because of the limitation of reporting of outcomes and hospi-
talization in most outbreaks, disease severity and case-fatality rates in the outbreaks cannot be assessed [36,37].
Applicability and implications for research
Enteric fever is one of the highly endemic diseases among the Asian and African countries [38,39], but unfor-
tunately, the regional surveillance system for the reporting of enteric fever is almost non-existent among the 
Asian and African countries [36,37], therefore there is a dire need to establish an association that reports inci-
dence, prevalence, hospitalization, complications, treatment outcome and mortality of enteric fever both at the 
community as well as at institutional level. The clinical signs and symptoms for enteric fever case diagnosis are 
not specific and they are often indistinguishable from other febrile illness[40]. Therefore, a thorough review 
of hospital records and clinical data of all suspected, probable, and confirmed cases of enteric fever can help 
in standardizing the case definition of enteric fever. The syndromic definition of enteric fever would result in 
series of positive outcomes. Like, it would aid in reducing the false positive cases of enteric fever and would 
also control the irrational empirical antibiotic use. Since the emergence of MDR, FQR and XDR cases are the 
results of irrational use of antibiotics therefore, the controlled practice of empirical antibiotic use would be a 
step for prevention and control of MDR, FQR and XDR cases [41].
In this systematic review we observed substantial variation in the diagnostic testing, and lack of any unified 
outbreak scoring or a standardized global checklist for the early identification and impact assessment of en-
teric fever outbreaks. An experience from the recent Ebola outbreak in West Africa provided an important 
Table 6. Enteric fever outbreak preventive measures (N = 15)
Source of outbreak Studies supporting Place of outbreak
Health education (n = 7)
Yan et al (2015) [21], Yan et al (2016) [22] China (n = 2)
Cherian et al (2014) [23] India (n = 1)
al-Zubaidy et al (1995) [24] Saudi Arabia (n = 1)
Jonathan et al (1999) [25] Tajikistan (n = 1)
Mwansa et al (2017) [26] Zambia (n = 1)
Imanishi M et al (2014) [27] Zimbabwe (n = 1)
Mass immunization (n = 4)
Yan et al (2016) [22] China (n = 1)
Meltzer et al (2013) [28] Nepal (n = 1)
Goh et al (1992) [29] Singapore (n = 1)
Bodhidatta et al (1987) [30] Thailand (n = 1)
Water disinfection and sanitary measures 
(n = 7)
Yan et al (2015) [21], Yan et al (2016) [22], Wang et al (2017) China (n = 3)
Cherian et al (2014) [23] India (n = 1)
Jonathan et al (1999) [25] Tajikistan (n = 1)
Mwansa et al (2017) [26] Zambia (n = 1)
Imanishi M et al (2014) [27] Zimbabwe (n = 1)
Building & construction of treatment 
plants and pipelines(n = 4)
Yan et. al, (2015) [21] China (n = 1)
Banerjee et al (2007) [31], Cherian et al (2014) [23]. India (n = 2)
Aye et al (2004) [32] Myanmar (n = 1)
Jonathan et al (1999) [25] Tajikistan(n = 1)
Legislation (n = 3)
Yan et al (2016) [22], Wang et al (2017) China (n = 2)
Teoh et al (1997) [33] Singapore (n = 1)
Others (n = 1) (Cholecystectomy of 
convalescent carriers)
Goh (1981) [34] Singapore (n = 1)
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lesson regarding the importance of initiating public health response early at the initial stages of an outbreak. 
Any delay in the early stages of an outbreak can result in an exponential increase in the scale of an outbreak, 
causing substantial follow-on effects [42,43]. A validated outbreak scale with the potential to predict the risk 
of an outbreak of a particular disease in an early stage can be beneficial in identifying outbreaks of catastroph-
ic potential [44]. Several studies have reported the utility of outbreak scales containing various pathogen and 
country-specific parameters for example the novelty of the causative agent, its virulence (resistance to avail-
able antibiotics), incidence rate, fatality rate, source of transmission, availability of treatment/vaccine, popu-
lation density especially susceptible population, political stability, preparedness of local health care system to 
deal with the outbreak, and availability of local financial, technical and trained human resources, for the time-
ly identification of outbreaks of other infectious diseases eg, Middle East Respiratory Syndrome coronavirus 
(MERS-CoV), severe acute respiratory syndrome (SARS), and Ebola [44,45]. Likewise, global risk assessment 
tools are available for the early detection of polio, measles and dengue outbreaks which are globally used in 
several endemic countries as a decision support tool for the characterization of an outbreak and prioritization 
of response [46-48]. We recommend the development of a unified enteric fever outbreak scoring framework 
for early identification and prioritization of the public health response.
The spread of disease can be prevented by identifying the population at risk. Every person is at equal risk 
of getting the disease, but travellers are more likely to transmit the infection to others [49,50]. International 
travellers from Pakistan, India, Bangladesh, Mexico, Haiti, and the Philippines largely contribute to the inter-
national transmission of typhoid fever [49]. Therefore, introducing an active immunization strategy against 
Typhoid can aid in controlling the spread [44] of typhoid fever from the carriers to the healthy population. 
The typhoid carriers living in typhoid endemic countries can transmit typhoid infection in typhoid-free com-
munities and nations very easily [51]. Different advisory bodies of the developed nations, ie, CDC of United 
States of America, CATMAT (Committee to Advise Tropical Medicine and Travel) of Canada and NaTHANaC 
(National Travel Health Network and Center) of the United Kingdom all have recommended typhoid vacci-
nation for travellers and high-risk group people travelling to high-risk typhoid region [52-54]. Hence, im-
munizing the people of developing nations against typhoid vaccine could aid in preventing the geographical 
penetration of the disease.
An epidemiological transition has been observed among the cases of enteric fever. Children under 15 years of 
age are more vulnerable to enteric fever compared to adults. Vaccination against Typhoid is the sustainable 
solution stated by Coalition Against Typhoid (CAT) [55]. Many studies also supported typhoid vaccination for 
the prevention of typhoid fever [56-58]. Thus, the typhoid vaccine will provide multiple benefits not limited 
to outbreak prevention, but it will also reduce antimicrobial resistance and irrational empirical treatment via 
broad-spectrum antibiotics [59].
In future, the researchers must focus on assessing the knowledge gap and on implementing the effectiveness 
of different prevention strategy for reducing the disease episodes and burden. Moreover, countries must focus 
on water chlorination, water plant and sewerage plant infrastructure development and legislation for proper 
sanitation, hygiene and vaccinations among the food handlers, health care workers, international travellers and 
other high-risk groups of individuals and communities. Also, there is a global need of developing a unified 
enteric fever outbreak scores or checklist to detect outbreak at an early stage and prioritize timely response.
Strengths and limitations
This review has certain strengths, such as the use of the breadth of databases, inclusion of original research ar-
ticles reporting a single outbreak, and inclusion of last 50 years data of all typhoid, and paratyphoid outbreaks 
that occurred in Asia and Africa. However, the exclusion of the studies which were published in languages 
other than English weaken the internal validity of this review, and there are many Asian and African countries 
where the native language is used for scientific publication and reporting. Because of this exclusion, the litera-
ture retrieved for this study does not represent the actual outbreak events among Asian and African countries. 
Further, there is also a potential issue of cohort effect due to the inclusion of 50-year retrospective records eg, 
further back in the past you go, the less likely it is for an epidemic to be published. The cohort effect might 
have resulted in the bias of unknown effect and even direction, it might easily be the case that only the severe 
one’s outbreaks were published in the past, while even smaller get published today. The problem is a constant 
change in the landscape including hygiene and sanitation, making the longer-term comparison less likely to 
be directly comparable. Moreover, due to the heterogenicity of reporting mechanism and outcomes, quality 
assessment and meta-analysis of was not done.
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CONCLUSION
Our review highlights the variability in detection and reporting methods for enteric fever. Case definitions and 
laboratory methods for the diagnosis of enteric fever cases were not standardized. There is lack of a standard-
ized “tool kit” for containing the outbreak if an event happens. This review highlights the necessity of the de-
velopment of a unified enteric fever outbreak scale or a standardized global scoring system for the early iden-
tification of an outbreak and prioritization of public health response.
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